Michael H Gelb Selected Research

Metachromatic Leukodystrophy (Sulfatide Lipidosis)

3/2024	Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
1/2023	Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix.
1/2021	Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots.
1/2016	Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples.
6/2014	Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael H Gelb Research Topics

Disease

24	Inflammation (Inflammations) 01/2022 - 05/2002
14	Mucopolysaccharidoses 04/2024 - 01/2011
13	Asthma (Bronchial Asthma) 01/2021 - 04/2007
13	Neoplasms (Cancer) 01/2016 - 10/2003
11	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2023 - 01/2007
9	Globoid Cell Leukodystrophy (Krabbe Disease) 11/2022 - 03/2004
9	Malaria 06/2015 - 02/2003
8	Glycogen Storage Disease Type II (Pompe's Disease) 12/2022 - 10/2004
7	Mucopolysaccharidosis I (Hurler Syndrome) 01/2022 - 12/2008
7	African Trypanosomiasis (Nagana) 01/2017 - 08/2002
7	Chagas Disease (American Trypanosomiasis) 12/2013 - 08/2005
6	Respiratory Hypersensitivity 01/2021 - 01/2013
5	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024 - 03/2012
5	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 03/2024 - 06/2014
5	Mucopolysaccharidosis II (Hunter Syndrome) 01/2022 - 01/2007
4	Mucopolysaccharidosis IV (Morquio Syndrome) 03/2020 - 10/2010
4	Fabry Disease (Fabry's Disease) 01/2020 - 10/2011
4	Infections 10/2011 - 02/2003
4	Atherosclerosis 10/2010 - 01/2008
3	Multiple Sulfatase Deficiency Disease (Mucosulfatidosis) 12/2023 - 01/2023
3	Inborn Errors Metabolism (Inborn Errors of Metabolism) 11/2023 - 08/2014
3	Wolman Disease (Wolman's Disease) 12/2022 - 01/2018
3	Porphyrias (Porphyria) 08/2010 - 04/2008
3	Parasitic Diseases (Parasitic Disease) 02/2009 - 02/2003
3	Progeria (Hutchinson Gilford Syndrome) 10/2005 - 07/2005
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2024 - 01/2018
2	Rare Diseases (Rare Disease) 10/2023 - 06/2020
2	Cerebrotendinous Xanthomatosis 01/2023 - 10/2020
2	Cholesterol Ester Storage Disease 12/2020 - 01/2018
2	Arthritis (Polyarthritis) 01/2019 - 05/2010
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 10/2018 - 08/2014
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016 - 01/2005
2	Metaplasia 08/2011 - 04/2007
2	Rheumatoid Arthritis 01/2011 - 05/2010
2	Carcinogenesis 10/2009 - 09/2007
2	Colonic Neoplasms (Colon Cancer) 10/2009 - 09/2007
2	Neoplasm Metastasis (Metastasis) 03/2009 - 10/2004
2	Prostatic Neoplasms (Prostate Cancer) 12/2008 - 10/2004
2	Bacterial Infections (Bacterial Infection) 01/2008 - 03/2005
2	Atopic Dermatitis (Atopic Eczema) 05/2002 - 04/2002

Drug/Important Bio-Agent (IBA)

54	EnzymesIBA 11/2023 - 01/2003
31	Secretory Phospholipases A2IBA 01/2020 - 07/2003
13	Phospholipases (Phospholipase)IBA 01/2022 - 08/2002
13	EicosanoidsIBA 01/2021 - 10/2004
13	Group X Phospholipases A2IBA 01/2020 - 01/2005
12	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2017
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2003
8	GlycosaminoglycansIBA 04/2024 - 01/2020
6	AcidsIBA 04/2024 - 10/2004
6	CytokinesIBA 01/2020 - 04/2007
6	Arachidonic Acid (Vitamin F)IBA 05/2013 - 10/2004
6	p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA 01/2008 - 08/2002
5	GalactosylceramidaseIBA 11/2022 - 08/2017
5	Iduronidase (alpha-L-Iduronidase)IBA 01/2022 - 12/2008
5	AllergensIBA 01/2020 - 04/2007
5	tipifarnib (R115777)IBA 01/2019 - 08/2005
5	Phospholipases A2 (Phospholipase A2)IBA 11/2017 - 10/2009
5	LipidsIBA 01/2016 - 10/2009
5	Group II Phospholipases A2IBA 01/2016 - 04/2002
4	Sulfoglycosphingolipids (Sulfatides)IBA 03/2024 - 06/2014
4	Cerebroside-Sulfatase (Arylsulfatase A)IBA 03/2024 - 01/2016
4	SulfatasesIBA 12/2023 - 11/2010
4	Psychosine (Galactosylsphingosine)IBA 01/2022 - 01/2020
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 07/2003
3	GalactosidasesIBA 01/2021 - 10/2011
3	GlucosidasesIBA 07/2017 - 08/2013
3	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 12/2015 - 11/2010
3	LipopolysaccharidesIBA 03/2015 - 04/2002
3	Heme (Haem)IBA 08/2010 - 04/2008
3	TransferasesIBA 10/2005 - 02/2003
2	HydrolasesIBA 11/2023 - 06/2023
2	N-formylglycineIBA 10/2023 - 01/2023
2	Galactosylceramides (Galactocerebrosides)IBA 01/2022 - 01/2020
2	Surface-Active Agents (Surfactants)IBA 01/2021 - 07/2003
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2020 - 01/2018
2	CholesterolIBA 01/2019 - 07/2011
2	LysophospholipidsIBA 11/2017 - 10/2010
2	AntigensIBA 11/2017 - 12/2016
2	Antiparasitic Agents (Antiparasitics)IBA 01/2017 - 02/2014
2	OvalbuminIBA 12/2016 - 04/2007
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2015 - 10/2004
2	varespladibIBA 03/2015 - 11/2009
2	Lipase (Acid Lipase)FDA Link 07/2014 - 05/2013
2	CarboxypeptidasesIBA 05/2014 - 01/2010
2	Tryptases (Tryptase)IBA 05/2014 - 01/2010
2	SterolsIBA 12/2013 - 09/2012
2	Group V Phospholipases A2IBA 01/2013 - 05/2010
2	Protein Glutamine gamma Glutamyltransferase 2IBA 12/2012 - 01/2010
2	posaconazole FDA Link 09/2012 - 06/2009
2	LanosterolIBA 05/2010 - 06/2009
2	Phospholipases AIBA 05/2010 - 07/2003
2	AndrogensIBA 12/2008 - 10/2004
2	Group IV Phospholipases A2IBA 12/2008 - 03/2005
2	Farnesyltranstransferase (Farnesyltransferase)IBA 09/2008 - 02/2008
2	LeukotrienesIBA 12/2007 - 04/2002
2	alpha-Glucosidases (Acid Maltase)IBA 04/2006 - 10/2004
2	Acarbose FDA LinkGeneric 04/2006 - 10/2004
2	prelamin AIBA 09/2005 - 07/2005

Therapy/Procedure

15	Therapeutics 03/2024 - 02/2003
3	Enzyme Replacement Therapy 12/2022 - 01/2018